Past Event

Should we revisit the patent system for pharmaceutical products?

Analysis of the legal issues with the current IP system for regulated market authorisations for pharmaceutical products, as well as its economic effects.

Date: July 9, 2018, 12:30 pm Topic: Innovation & Competition Policy

video & audio recordings

summary

The panel set themselves to address some fundamental questions about the European patent system and how it affects the pharmaceutical sector, as the pharmaceutical industry represents roughly 30% of all the EU R&D spending. They discussed the proposal put forward by the Commission about a reform of the supplementary protection certificate, which extends pharmaceutical companies’ patent protection for an additional 5 years maximum as a compensation for the years of patent term lost for the development of the patented product prior to effective market entry. In order to boost jobs creation in generics and biosimilars manufacturing and to alleviate some of the concerns about access to medicines, the reform would introduce a waiver for generic and biosimilar manufacturers’ exports outside the EU. This would allow them to manufacture generic and biosimilar versions of protected products and to sell them abroad without fees to patent-owners. The private sector is however concerned this initiative reduces IP rights, while recognizing the Commission’s efforts to introduce safeguards with regards to labelling and stockpiling.

The panel then discussed two studies that explored the legal and economic aspects of the proposed reforms. Economically, intellectual property protection in the pharmaceutical industry is found to incentivise innovation, but is negative for access to the molecules developed. Indeed, protection results in a significantly higher price compared to when competition from generic versions of the products enter the market. From a legal perspective, the reform is found to be necessary as the Court of Justice of the EU has taken decisions that have led to a divergence from the legal basis: reducing that divergence, either by codifying case law or addressing the ambiguities in the legal basis.

Participants then discussed some of the shortcomings of the current patent system in general. Some of the key issues of the current systems on which most participants seem to agree was the need to unify the EU intellectual property framework and the need to consider the global aspect of intellectual property legislation. Indeed, participants agreed that the current system is very fragmented, with 28 regulators, 28 sets of rules and 28 times the amount of administrative costs – for 28 nations that aspire to form a single market, this was perceived as inefficient. Furthermore, participants mentioned how other nations’ own legislative templates were influenced by the EU’s system and that there existed international agreements. These therefore limit the degrees of freedom the EU has to reform. However, the pharmaceutical industry clarified that duration of intellectual property protection was generally not a factor in selecting a location for establishing activities.

More broadly, participants and the audience discussed how other incentives for innovation in the EU had been left out of the debate, as well as fundamental problems. Because the real benefits of innovation cannot be known ex ante, intellectual property protection has always been a sort of trade-off between incentivisation and access. There was an agreement that, in addition of the traditional patent protection, other incentivisation mechanisms should be better leveraged for innovation, such as public funding for research, prizes, Europe-wide industrial policy, pricing policy or universities’ royalty system. In terms of more fundamental reforms of the patenting system, the audience suggested thinking of a system that factors in the profitability of innovation rather than merely the revenue side. They also highlighted the need to tackle “fake innovation” and abuse of the intellectual property system that stymies innovation, noting the importance of having transparent system with clear criteria for granting protection.

event materials

Study on the economic impact of supplementary protection certificates, pharmaceutical incentives and rewards in Europe, by Copenhagen Economics (call for tender 590/PP/GRO/SME/16/F/121)

Schedule

Jul 9, 2018

12:30-13:00

Check-in and lunch

13:00-14:00

Panel discussion

Chair: Reinhilde Veugelers, Senior Fellow

Arno Hartmann, Member of EFPIA's IP expert group

Christian Jervelund, Head Health Care and Life Sciences services, Copenhagen Economics

Margaret K. Kyle, Professor of Economics, Center for Industrial Economics (CERNA), MINES ParisTech (Ecole des Mines)

Roberto Romandini, Senior Research Fellow, Max Planck Institute for Innovation and Competition

Amaryllis Verhoeven, Head of Unit, Industrial Property and the Fight against Counterfeiting, European Commission

Bruno van Pottelsberghe, Former Non-Resident Fellow

14:00-14:30

Q&A

14:30

End

Speakers

Arno Hartmann

Member of EFPIA's IP expert group

Christian Jervelund

Head Health Care and Life Sciences services, Copenhagen Economics

Margaret K. Kyle

Professor of Economics, Center for Industrial Economics (CERNA), MINES ParisTech (Ecole des Mines)

Roberto Romandini

Senior Research Fellow, Max Planck Institute for Innovation and Competition

Bruno van Pottelsberghe

Former Non-Resident Fellow

Amaryllis Verhoeven

Head of Unit, Industrial Property and the Fight against Counterfeiting, European Commission

Reinhilde Veugelers

Senior Fellow

Location & Contact

Bruegel, Rue de la Charité 33, 1210 Brussels

Katja Knezevic

[email protected]

Read about event More on this topic
 

Upcoming Event

Sep
2
14:30

Brave new digital industrial policy

Bruegel Annual Meetings, Day 2 - In this session our speakers will dicuss innovation and digitalisation.

Speakers: Francesca Bria, Kerstin Jorna, Marietje Schaake and Reinhilde Veugelers Topic: Innovation & Competition Policy Location: Palais des Académies, Rue Ducale 1, Brussels
Read about event More on this topic
 

Past Event

Past Event

Investment firepower for the recovery: a conversation with Philippe Donnet, CEO of Assicurazioni Generali

At this event the CEO of Assicurazioni Generali, Philippe Donnet will be in conversation with Guntram Wolff, Director of Bruegel.

Speakers: Philippe Donnet and Guntram B. Wolff Topic: European Macroeconomics & Governance Date: July 8, 2021
Read about event More on this topic
 

Past Event

Past Event

Strengthening the weak links: future of supply chains

What new supply chains trends will we see in the post-pandemic era?

Speakers: Ebru Özdemir, André Sapir and Guntram B. Wolff Topic: Global Economics & Governance Date: July 7, 2021
Read about event
 

Past Event

Past Event

Ensuring competitiveness of low-carbon investments

At this event, speakers will introduce the core idea of commercialisation contracts, and then discuss key design elements. This includes whether contracts should be issued at the EU or national level, how competition for contracts should be organised, and which industries should be eligible for support.

Speakers: Natalia Fabra, Peter Handley, Ben McWilliams and Georg Zachmann Topic: Energy & Climate, European Macroeconomics & Governance Date: July 1, 2021
Read article More on this topic
 

Blog Post

Workers can unlock the artificial intelligence revolution

Employers and artificial intelligence developers should ensure new technologies work for workers by making them trustworthy, easy to use and valuable in day-to-day work.

By: Mia Hoffmann and Laura Nurski Topic: Innovation & Competition Policy Date: June 30, 2021
Read about event More on this topic
 

Past Event

Past Event

EU debt vs national debts: friends or foes?

The EU will become into a major issuer of safe assets in the coming years. How will this interact with the debt issuance of European sovereign debts?

Speakers: Grégory Claeys, Yves Jacob, Gert-Jan Koopman, Pablo de Ramón-Laca and Imène Rahmouni-Rousseau Topic: European Macroeconomics & Governance Date: June 29, 2021
Read about event More on this topic
 

Past Event

Past Event

How to spend it? A closer look at the recovery plans

In this event, participants will take a closer look at the recovery plans submitted by EU countries.

Speakers: Zsolt Darvas, Alex Patelis and Maarten Verwey Topic: European Macroeconomics & Governance Date: June 23, 2021
Read about event More on this topic
 

Past Event

Past Event

Conference on the Future of Europe: Vehicle for reform versus forum for reflection?

At this policy dialogue organised by the research project EU3D, panellists will discuss different options and what they may entail while revisiting the debates on the future of Europe at national and EU-level that have been conducted thus far and their patterns, including preliminary findings on national parliamentary debates.

Speakers: Sergio Fabbrini, John Erik Fossum, Magdalena Góra, Vivien Schmidt, Manfred Weber and Guntram B. Wolff Topic: European Macroeconomics & Governance Date: June 16, 2021
Read article Download PDF More on this topic
 

Working Paper

Platform mergers and antitrust

This paper sets out a framework for addressing competition concerns arising from acquisitions in big platform ecosystems. This is a June 2021 update of the same paper published in January 2021.

By: Geoffrey Parker, Georgios Petropoulos and Marshall Van Alstyne Topic: Innovation & Competition Policy Date: June 15, 2021
Read article More on this topic
 

Blog Post

The coming productivity boom

AI and other digital technologies have been surprisingly slow to improve economic growth. But that could be about to change.

By: Erik Brynjolfsson and Georgios Petropoulos Topic: Innovation & Competition Policy Date: June 10, 2021
Read about event More on this topic
 

Past Event

Past Event

The Recovery and Resilience Fund: Accelerating the digitalisation of the EU?

How can new EU funds financed by EU borrowing supplement national digital and green funding and EU funds available from the standard seven-year EU budget to accelerate digitalisation?

Speakers: Sam Blackie, Zsolt Darvas, Maria Teresa Fabregas Fernandez, J. Scott Marcus and Ben Wreschner Topic: European Macroeconomics & Governance Date: June 8, 2021
Read about event More on this topic
 

Past Event

Past Event

Women, Covid-19 & The EU Recovery Plan

How can we ensure that the recovery plan doesn’t leave women behind when 84% of working women in the EU aged 15-64 are employed by services that were predominantly impacted by Covid-19 restrictions?

Speakers: Mary Collins, Maria Demertzis, Alexandra Geese, Jacob Funk Kirkegaard, Dan Mobley, Naomi O'Leary and Emma Rainey Topic: European Macroeconomics & Governance Date: June 2, 2021
Load more posts